Sørensen M, Schröder R, Mueller T C. "一种的合成方法" [P]. European Patent, EP 3374178 A1, 2018-06-02.
Chen K W, Klinger H, Roberts E F. "Method for the Synthesis of Methyl 2-((4-amino-1,2,5-oxadiazol-3-yl)oxy)acetate" [P]. US Patent, US 9670648 B2, 2021-10-06.
Kumar R, Patel M V, Lee S K. "A Process for Preparing High-Purity Methyl 2-((4-amino-1,2,5-oxadiazol-3-yl)oxy)acetate" [P]. US Patent, US 10593497 B2, 2017-09-25.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2024, 1610, (7), 2341-2359.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2014, 2207, (5), 2503-2532.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 2-((4-amino-1,2,5-oxadiazol-3-yl)oxy)acetate Using HRMS and NMR". Chemosphere, 2017, 90, 4031-4058.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2019, 1325, 5513-5525.